跳至主要内容
临床试验/ISRCTN65756724
ISRCTN65756724进行中(未招募)2 期

Doxycycline 200mg/d vs 100mg/d for 6 weeks to improve filarial lymphedema: a multi-national, double-blind, randomized, placebo-controlled trial

The National Institute of Medical Research (NIMR)0 个研究点目标入组 420 人开始时间: 2017年7月25日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
420

研究概览

简要总结

2020 protocol in https://www.ncbi.nlm.nih.gov/pubmed/32228663 (added 02/04/2020)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Lymphedema of at least one leg grade 1-6 measured on a 7-point scale [3]
  • 2. Age = 14 years and = 65 years
  • 3. Men or non-pregnant women. If women of childbearing-potential, they must use an approved, effective method of contraception (including abstinence) before, during and for at least 2 weeks after the completion of the active intervention with doxycycline or placebo
  • 4. Negative pregnancy test
  • 5. Body weight = 40 kg
  • 6. Resident in LF endemic area for = 2 years
  • 7. Able and willing to give informed consent/ to provide assent to participate in the trial
  • 8. Ability to use established standardized methods of hygiene and effectively applying it prior to the initiation of the drug treatment

排除标准

  • 1. No lymphedema or lymphedema stage 7
  • 2. Age < 14 years or > 65 years
  • 3. Body weight < 40 kg
  • 4. Pregnant or breastfeeding women
  • 5. Women of childbearing potential not using an agreed method of contraception (including abstinence; oral contraceptives are not allowed because of interaction with trial drugs)
  • 6. Clinical or biologic evidence of hepatic or renal dysfunction or disease of the central nervous system (CNS)
  • 7. Evidence of severe comorbidities except for features of filarial disease
  • 8. Alcohol or drug abuse
  • 9. History of adverse reactions to doxycycline or other tetracyclines
  • 10. Any significant condition (including medical and psychological/ psychiatric disorder) which in the opinion of the study investigator might interfere with the conduct of the study
  • 11. History of photosensitivity reactions after taking drugs.
  • 12. Concomitant medication with antacids containing aluminium, magnesium or sucralfate and not able to discontinue
  • 13. Concomitant medication with other antibiotics than doxycycline and not able to discontinue
  • 14. Concomitant medication with diuretics or sulfonylurea
  • 15. Concomitant medication with coumarin
  • 16. Haemoglobin < 8 gm/dL
  • 17. Neutrophil count <2000/mm3 - updated 03/08/2018: Neutrophil count <1100/mm3
  • 18. Platelet count <100,000/mm3
  • 19. Creatinine > 2 times upper limit of normal
  • 20. AST (GOT) > 2 times upper limit of normal
  • 21. ALT (GPT) > 2 times upper limit of normal
  • 22. Gamma-GT > 2 times upper limit of normal
  • 23. Positive urine pregnancy test

研究者

发起方
The National Institute of Medical Research (NIMR)

相似试验